Literature DB >> 11026153

HIV risk and prevention in emergency-affected populations: a review.

A J Khaw1, P Salama, B Burkholder, T J Dondero.   

Abstract

While basic guidelines on HIV prevention in emergencies have been available for several years, international agencies involved in the provision of health services have not placed sufficient priority on the prevention of the human immune deficiency virus (HIV) and other sexually transmitted infections (STIs) in complex emergencies. This paper reviews the factors that may increase the risk of HIV transmission in populations affected by complex emergencies and outlines recommendations for research and programmes. Research into the most appropriate methods of carrying out HIV surveillance and interventions in these settings is needed. In the post-emergency phase programmes need to be far more extensive than those offered under the Minimal Initial Services Package (MISP). While the potential for stigmatization represents an important constraint, there is a need to prioritize HIV/STI interventions in order to prevent HIV transmission in emergency-affected populations themselves, as well as to contribute to regional control of the epidemic.

Entities:  

Mesh:

Year:  2000        PMID: 11026153     DOI: 10.1111/1467-7717.00141

Source DB:  PubMed          Journal:  Disasters        ISSN: 0361-3666


  19 in total

1.  The prevalence of HIV, HBV, HCV, and HIV-related risk-taking behaviors among Palestinian injecting drug users in the East Jerusalem Governorate.

Authors:  Aleksandar Stulhofer; Agnes Chetty; Randa Abu Rabie; Isam Jwehan; Asad Ramlawi
Journal:  J Urban Health       Date:  2012-08       Impact factor: 3.671

Review 2.  What's in a label? Learning from the HIV-TB deadly symbiosis.

Authors:  Rachel Klein
Journal:  Afr Health Sci       Date:  2004-12       Impact factor: 0.927

3.  Armed Conflict, Substance Use and HIV: A Global Analysis.

Authors:  Bradley T Kerridge; Tulshi D Saha; Deborah S Hasin
Journal:  AIDS Behav       Date:  2016-03

Review 4.  Analysis of social epidemiology research on infectious diseases: historical patterns and future opportunities.

Authors:  Justin M Cohen; Mark L Wilson; Allison E Aiello
Journal:  J Epidemiol Community Health       Date:  2007-12       Impact factor: 3.710

5.  Trends of HIV-1 and HIV-2 prevalence among pregnant women in Guinea-Bissau, West Africa: possible effect of the civil war 1998 1999.

Authors:  Fredrik Månsson; Alfredo Alves; Zacarias José da Silva; Francisco Dias; Sören Andersson; Gunnel Biberfeld; Eva Maria Fenyö; Hans Norrgren
Journal:  Sex Transm Infect       Date:  2007-07-04       Impact factor: 3.519

6.  An HIV/STI prevention intervention for internally displaced women in Leogane, Haiti: study protocol for an N-of-1 pilot study.

Authors:  Carmen H Logie; Carolann Daniel; Peter A Newman; Mona R Loutfy
Journal:  BMJ Open       Date:  2012-07-18       Impact factor: 2.692

7.  Vulnerability to high risk sexual behaviour (HRSB) following exposure to war trauma as seen in post-conflict communities in eastern uganda: a qualitative study.

Authors:  Eugene Kinyanda; Margaret Mungherera; Patrick Onyango; Emmanuel Ngabirano; Julius Muron; Johnson Kagugube; Rehema Kajungu; Wilson Winstons Muhwezi
Journal:  Confl Health       Date:  2011-10-19       Impact factor: 2.723

8.  Conflict and HIV: A framework for risk assessment to prevent HIV in conflict-affected settings in Africa.

Authors:  Nancy B Mock; Sambe Duale; Lisanne F Brown; Ellen Mathys; Heather C O'maonaigh; Nina Kl Abul-Husn; Sterling Elliott
Journal:  Emerg Themes Epidemiol       Date:  2004-10-29

9.  HIV/AIDS, conflict and security in Africa: rethinking relationships.

Authors:  Joseph U Becker; Christian Theodosis; Rick Kulkarni
Journal:  J Int AIDS Soc       Date:  2008-09-22       Impact factor: 5.396

10.  HIV-1 prevalence and factors associated with infection in the conflict-affected region of North Uganda.

Authors:  Massimo Fabiani; Barbara Nattabi; Chiara Pierotti; Filippo Ciantia; Alex A Opio; Joshua Musinguzi; Emintone O Ayella; Silvia Declich
Journal:  Confl Health       Date:  2007-03-01       Impact factor: 2.723

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.